+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 39 Pages
  • July 2023
  • GlobalData
  • ID: 1495426
TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions
  • Corporate strategy - Analyst’s summarization of the company’s business strategy
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats
  • Company history - Progression of key events associated with the company
  • Major products and services - A list of major products, services and brands of the company
  • Key competitors - A list of key competitors to the company
  • Key employees - A list of the key executives of the company
  • Executive biographies - A brief summary of the executives’ employment history
  • Key operational heads - A list of personnel heading key departments/functions
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history


TransGenic Inc (TransGenic) is a biotechnology company that develops and distributes genetically engineered animals and antibodies and licensing of these activities. The company’s product portfolio and services include knockout mouse and phenotype database, custom production of antibodies and proteins, genetically engineered mice, custom production of knock out mouse, drug discovery and contract services for non-clinical study, support services, mouse related products, and antibody related products. TransGenic provides gene analysis and nonclinical study using disease-animal model. The company’s technologies include genetically engineered mouse knock in mouse and knockout mouse; genome editing technology; exchangeable Gene-trap method, among others. It has Kobe research center located in Japan. TransGenic is headquartered in Fukuoka City, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • TransGenic Inc - Key Facts
  • TransGenic Inc - Key Employees
  • TransGenic Inc - Key Employee Biographies
  • TransGenic Inc - Major Products and Services
  • TransGenic Inc - History
  • TransGenic Inc - Company Statement
  • TransGenic Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • TransGenic Inc - Business Description
  • Business Segment: Drug Discovery Support Business
  • Overview
  • Performance
  • Business Segment: Investment and Consulting Business
  • Overview
  • Performance
  • R&D Overview
  • TransGenic Inc - Corporate Strategy
  • TransGenic Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • TransGenic Inc - Strengths
  • TransGenic Inc - Weaknesses
  • TransGenic Inc - Opportunities
  • TransGenic Inc - Threats
  • TransGenic Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • TransGenic Inc, Recent Deals Summary
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • TransGenic Inc, Key Facts
  • TransGenic Inc, Key Employees
  • TransGenic Inc, Key Employee Biographies
  • TransGenic Inc, Major Products and Services
  • TransGenic Inc, History
  • TransGenic Inc, Other Locations
  • TransGenic Inc, Subsidiaries
  • TransGenic Inc, Key Competitors
  • TransGenic Inc, Ratios based on current share price
  • TransGenic Inc, Annual Ratios
  • TransGenic Inc, Interim Ratios
  • TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • TransGenic Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • TransGenic Inc, Performance Chart (2019 - 2023)
  • TransGenic Inc, Ratio Charts
  • TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • TransGenic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ABIONYX Pharma SA
  • Anhui Anke Biotechnology (Group) Co Ltd
  • Daiichi Sankyo Taiwan Ltd
  • Otsuka Pharmaceutical Co Ltd
  • Central Institute for Experimental Animals